Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Besides the front-line maintenance therapy, is any positive impact of poly (ADP-ribose) polymerase (PARP) inhibitors on recurrent high-grade ovarian cancer?
Yiu-Tai Li & Peng-Hui Wang
Links
DOI
PubMed
Journal
Taiwanese Journal of Obstetrics and Gynecology
Authors
Yiu-Tai Li
,
Peng-Hui Wang